BAJAJ BROKING
Dr. Lal PathLabs reported a 9.8% revenue growth to ₹660 crore in Q2 FY24-25, while PAT increased by 18.1% to ₹130 crore. Growth was driven by core diagnostic services and wellness testing, reflecting the company’s market leadership and operational excellence.
Dr. Lal PathLabs Limited reported a consolidated revenue of ₹660 crore, showing a 9.8% increase year-on-year for Q2 FY24-25. The company also recorded a Profit After Tax (PAT) of ₹131 crore, reflecting an 18.1% YoY growth. The diagnostics giant continues to perform strongly despite evolving market conditions, maintaining its leadership in diagnostic services across India.
Dr. Lal PathLabs posted consolidated revenue of ₹660 crore in Q2 FY24-25, a 9.8% year-on-year increase compared to ₹601 crore in Q2 FY23-24. The company's Profit After Tax (PAT) for the quarter stood at ₹131 crore, marking an 18.1% growth compared to ₹111 crore in the same period last year. The robust performance is driven by continued demand for diagnostic services and the company’s expansion into new test categories.
Dr. Lal PathLabs’ Q2 results align with sector expectations, reflecting steady growth in the diagnostics market, driven by increasing demand for preventive healthcare services and routine testing. The sector continues to expand as awareness about health monitoring increases. The company's focus on wellness testing, along with a broad diagnostic portfolio, positions it strongly for future growth.
Dr. Lal PathLabs considered & took note that Dr. Om Prakash Manchanda will be stepping down as Managing Director of the Company on account of completion of tenure on March 31, 2025 (closing of business hours). However, after completion of tenure as Managing Director, he will remain as an advisor to the Company.
Particulars | Q2 FY24-25 (Reported) | YoY Change |
Revenue | ₹660.2 Cr | 9.80% |
EBITDA Margin | 30.70% | 13.90% |
PAT | ₹130.8 Cr | 18.10% |
Second Interim Dividend per Share | ₹ 6 |
|
Dr. Lal PathLabs’ Q2 FY24-25 results highlight its strong financial performance, with revenue growing by 9.8% and PAT increasing by 18.1%. The company’s ongoing focus on expanding its diagnostic portfolio and preventive health offerings continues to fuel growth, positioning it as a leader in the diagnostics industry.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
BEL Secures Orders Worth ₹973 Crore, Achieves 40% of FY25 Target
24 Dec, 2024 | 2 Min. read
Adani Defence Acquires 85.8% Stake in Air Works for ₹400 Crore
24 Dec, 2024 | 2 Min. read
US FDA Restricts Imports of Viatris Drugs Manufactured at Indian Facility
24 Dec, 2024 | 2 Min. read
TVS Motor Acquires Majority Stake in DriveX with 87.38% Holding
24 Dec, 2024 | 2 Min. read
Share Market Today | Gift Nifty Hints At Flat Opening; Nifty Likely In 23,600-23,900
24 Dec, 2024 | 4 Min. read
Gold Price in India | Gold Prices Gain as Dollar and Yields Ease
23 Dec, 2024 | 40 Min. read
NTPC Green Energy Partners with Bihar for Renewable Energy Push
23 Dec, 2024 | 2 Min. read
NHPC to Invest ₹5,500 Crore in Bihar for Solar, Green Hydrogen
23 Dec, 2024 | 2 Min. read
Piramal Enterprises Approves ₹2,000 Crore Fundraising Plan
23 Dec, 2024 | 2 Min. read
NSE to Exclude 16 Securities from F&O Contracts by Feb 28
23 Dec, 2024 | 2 Min. read
Share Market Today | Gift Nifty Hints At A Positive Start For Indian Markets
23 Dec, 2024 | 4 Min. read
How to Apply for Unimech Aerospace IPO & Check Allotment Status?
23 Dec, 2024 | 3 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading